Link between angiotensin II and TGF-β in the kidney

Mineral and Electrolyte Metabolism

Volumn 24, Issue 2-3, 1998, Pages 174-180

  Wolf, Gunter ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Glomerulosclerosis; Hypertrophy; Progression of renal disease; Tubulointerstitial fibrosis

Indexed keywords

ANGIOTENSIN; COLLAGENASE; CYCLOSPORIN A; TRANSFORMING GROWTH FACTOR BETA;

DIABETIC NEPHROPATHY; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY; KIDNEY FAILURE; KIDNEY SCAR; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; URETER OBSTRUCTION;

ANGIOTENSIN II; ANIMALS; GENE EXPRESSION; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031932140     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057367     Document Type: Review

References (56)

1. Border WA, Noble NA: Cytokines in kidney disease: The role of transforming growth factor-β. Am J Kidney Dis 1993;22:105-113.
2. Roberts AB, McCune BK, Sporn MB: TGF-β: Regulation of extracellular matrix. Kidney Int 1992;41:557-559.
3. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 1994;266:F829-F842.
4. Wolf G, Neilson EG: Cellular biology of tubuIointerstitial growth. Curr Top Pathol 1995;88: 69-97.
5. Haberstroh U, Zahner G, Disser M, Thaiss F, Wolf G, Stahl RAK: TGF-β stimulates rat mesangial cell proliferation in culture: Role of PDGF β-receptor expression. Am J Physiol 1993;264:F199-F205.
6. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rats. J Clin Invest 1986;77:1993-2000.
7. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3:1531-1540.
8. Hahn AWA, Resink TJ, Bernhardt J, Ferracin F, Bühler FR: Stimulation of autocrine platelet-derived growth factor AA-homodimer and transforming growth factor β in vascular smooth muscle cells. Biochem Biophys Res Commun 1991;178:1451-1458.
9. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia: Autocrine transforming growth factor-β1 expression determines growth responses to an-giotensin II. J Clin Invest 1992;90:456-461.
10. Stouffer GA, Owens GK: Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res 1992;70: 820-828.
11. Chua CC, Diglio CA, Siu BB, Chua BHL: Angiotensin II induces TGF-β1 production in rat heart endothelial cells. Biochim Biophys Acta 1994;1223:141-147.
12. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ: Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27:2347-2357.
13. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366-1372.
14. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990; 259:F768-F777.
15. 1 receptor. Nephrol Dial Transplant 1993;8: 128-133.
16. Wolf G, Killen PD, Neilson EG: Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Regul 1991;2:219-227.
17. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose levels stimulate transforming growth factor-beta gene expression and bioactivity in murine proximal tubule cell culture. Kidney Int 1992;41:107-114.
18. Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN: The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 1991;176:902-909.
19. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: Attenuation after stable transfection with the c-mas oncogene. Kidney Int 1995; 48:1818-1827.
20. Geiser AG, Kim SJ, Roberts AB, Sporn MB: Characterization of the mouse transforming growth factor-β1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 1991;11: 84-92.
21. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M: The c-fos protein interacts with c-jun/ AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988;54:541-552.
22. Wolf G, Zahner G, Schroeder R, Stahl RAK: Transforming growth factor beta mediates the angiotensin II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant 1996; 11:263-269.
23. Wolf G, Neilson EG: Effects of angiotensin II on proximal tubular cells stably transfected with the c-mas oncogene. Am J Physiol 1992; 263:F931-F938.
24. Kip1. Kidney Int 1996;50:2112-2119.
25. 1 cells partly by decreasing transforming growth factor-β receptor protein expression. J Am Soc Nephrol 1996;7:1207-1215.
26. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994;93: 2431-2437.
27. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992;140:95-107.
28. Moriyama T, Fujiwara Y, Kaneko T, Xia C, Imai E, Kamada T, Ueda N: Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells. J Am Soc Nephrol 1995;6:95-101.
29. 1 receptors. Kidney Int 1994;45:177-184.
30. Horikoshi S, McCune BK, Ray PE, Kopp JB, Sporn MB, Klotman PE: Water deprivation stimulates transforming growth factor-β2 accumulation in the juxtaglomerular apparatus of mouse kidney. J Clin Invest 1991;88:2117-2122.
31. Ray PE, McCune BK, Gomez RA, Horikoshi S, Kopp JB, Klotman PE: Renal vascular induction of TGF-β2 and renin by potassium depletion. Kidney Int 1993;44:1006-1013.
32. Ray PE, McCune B, Gomez RA, Ruley EJ, Klotman PE: Expression of transforming growth factor β3 in hypertrophie juxtaglomerular apparatus. N Engl J Med 1994;330:68-69.
33. Ray PE, McCune BK, Geray KM, Carey RM, Klotman PE, Gomez RA: Modulation of renin release and renal vascular smooth muscle cell contractility by TGF-β2. Contrib Nephrol 1996;118:238-248.
34. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993;44:313-321.
35. Klahr S, Ishidoya S, Morrissey J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephopathy. Am J Kidney Dis 1995;26:141-146.
36. Hamaguchi A, Kim S, Ohta K, Yagi K, Yukimura T, Miura K, Fukuda T, Iwao H: Transforming growth factor-β1 expression and phenotypic modulation in the kidney of hypertensive rats. Hypertension 1995;26:199-207.
37. Wolf G, Schneider A, Stahl R:Losartan inhibits glomerular expression of TGF-β in 2 kidney-1 clip (2K-1C)hypertensive rats (abstract). Kidney Int 1996;50:1784.
38. Shankland SJ, Ly H, Thais K, Schoely JW: Increased glomerular capillary pressure alters glomerular cytokine expression. Circ Res 1994; 75:844-853.
39. Riser BL, Cortes B, Zhao X, Bernstein J, Dumler F, Narins RG: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992;90:1932-1943.
40. Harris RC, Akai Y, Yasuda T, Homma T: Role of physical factors in the regulation of mesangial cell growth and the interaction with vasoactive agents. Exp Nephrol 1994;2:104.
41. Wolf G, Thaiss F, Stahl RAK: Cyclosporine stimulates expression of transforming growth factor-β in renal cells. Transplantation 1995; 60:237-241.
42. Shehata M, Cope GH, Johnson TS, Raftery AT, El Nahas AM: Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney. Kidney Int 1995;48: 1487-1496.
43. Shihab FS, Andoh TF, Tanner AM, Noble NA, Border WA, Franceschini N, Bennett WM: Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996;49:1141-1151.
44. Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindsley J, Bennett WM: Prevention of experimental cyclosporininduced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995;269:F491-F499.
45. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I: Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991;40: 195-202.
46. Wolf G, Neilson EG: Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 1991;39:401-420.
47. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
48. Remuzzi A, Ferico N, Amuchastegui CS, Malanchini B, Mazerska M, Batraglia C, Bertanin T, Remuzzi G: Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993;4:40-49.
49. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High-glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 1992;42:647-656.
50. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 1994;93:536-542.
51. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997;29:153-163.
52. Khanna A, Li B, Suthanthiran M: Transforming growth factor-β1 : regulation with a TGF-β1 antisense oligomer. Kidney Int 1996;49 (suppl 53):S2-S6.
53. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 1990;346: 371-374.
54. Isaka Y, Bress DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 1996;2:418-423.
55. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.
56. Wolf G, Neilson EG: Angiotensin II as a renal cytokine. New Phys Sci 1994;9:40-42.